Soleus Capital Management, L.P. Cytosorbents Corp Transaction History

Soleus Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $3.24 Million - $6.49 Million	-800,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $5.6 Million - $7.77 Million	800,000 New	800,000 $6.5 Million
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $437,088 - $737,064	-69,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.77 - $7.73 $262,392 - $538,008	69,600 New	69,600 $538,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.